Evarrest Approval History
FDA Approved: Yes (First approved December 5, 2012)
Brand name: Evarrest
Generic name: fibrin sealant
Dosage form: Patch
Company: Ethicon, Inc.
Treatment for: Bleeding Disorder
Evarrest (fibrin sealant patch) is indicated for use with manual compression as an adjunct to hemostasis for problematic soft tissue bleeding during surgery.
Development History and FDA Approval Process for Evarrest
|Dec 7, 2012||FDA Approves Evarrest Fibrin Sealant Patch|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.